Wellvone and pyrexia Patient Reports February 12, 2012

Wellvone Side Effects Report #4947814-7
Wellvone side effect was reported by a Physician from FRANCE on Mar 16, 2006. Female patient, 30 years of age, was diagnosed with cerebral toxoplasmosis and was treated with Wellvone. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, dizziness , gamma-glutamyltransferase increased, headache , pyrexia, rash maculo-papular. Wellvone dosage: 750MG SEE TEXT. During the same period patient was treated with ALTHIAZIDE, PYRIMETHAMINE, HYDRALAZINE. Patient was hospitalized. Patient recovered.

Wellvone Side Effects Report #5647018-9
Wellvone side effect was reported by a Consumer or non-health professional from FRANCE on Feb 20, 2008. Female patient, 32 years of age, was diagnosed with tuberculosis , anxiety , insomnia, candidiasis and was treated with Wellvone. After drug was administered, patient experienced the following side effects: enanthema, face oedema, hepatocellular injury, lymphadenopathy, pyrexia, rash maculo-papular. Wellvone dosage: unknown. During the same period patient was treated with RIMIFON, RIFADIN, MYAMBUTOL, AMIKLIN, LEXOMIL, IMOVANE, MYCOSTATIN. Patient was hospitalized. Patient recovered.

Wellvone Side Effects Report #5702732-1
Wellvone side effect was reported by a Consumer or non-health professional from FRANCE on Mar 31, 2008. Male patient, 24 years of age, was treated with Wellvone. After drug was administered, patient experienced the following side effects: mucous membrane disorder, pyrexia, rash , rash erythematous, skin disorder, staphylococcal bacteraemia, toxic epidermal necrolysis. Wellvone dosage: unknown. During the same period patient was treated with TRIATEC, ATORVASTATIN CALCIUM, KARDEGIC, AMLOR, BRISTOPEN. Patient was hospitalized. Patient recovered.

Wellvone Side Effects Report #5789038-X
Wellvone side effect was reported by a Consumer or non-health professional from FRANCE on June 19, 2008. Male patient, 24 years of age, was treated with Wellvone. After drug was administered, patient experienced the following side effects: mucous membrane disorder, pyrexia, rash , rash erythematous, skin disorder, staphylococcal bacteraemia, toxic epidermal necrolysis. Wellvone dosage: unknown. During the same period patient was treated with RAMIPRIL, TAHOR, AMLOR, ASPIRIN, BRISTOPEN. Patient was hospitalized. Patient recovered.